United States · Funded startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$101Mraised across 3 rounds since 2004, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $60M sold, first sale Sept 2015
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kleiner Perkins Caufield & Byers
Domain Associates
Sofinnova InvestmentsWasatch AdvisorsMPM BioEquitiesBaupost GroupFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Orexigen Therapeutics's investors include Kleiner Perkins Caufield & Byers, Domain Associates, Sofinnova Investments, Wasatch Advisors and MPM BioEquities, and 1 more on record.
Orexigen Therapeutics has raised $101M across 3 rounds since 2004.
Orexigen Therapeutics's most recent round was an Undisclosed round of $60M in Sept 2015.
Its most recent round, $60M in Sept 2015, is also its largest on record.
Orexigen Therapeutics's first round on record, in Jan 2004, was backed by Kleiner Perkins Caufield & Byers, Domain Associates and Sofinnova Investments.
Orexigen Therapeutics's latest named round is an Undisclosed round, in Sept 2015.
Orexigen Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·